Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A non-neoplastic or neoplastic disorder that affects the pancreas. Representative examples of non-neoplastic disorders include pancreatitis and pancreatic insufficiency. Representative examples of neoplastic disorders include cystadenomas, carcinomas, lymphomas, and neuroendocrine neoplasms.
Biomarker and diagnostic research for pancreas disorder has been reported in the published literature.
56 clinical trials registered, 16 recruiting. Interventions under study include other interventions, medical devices, drug therapy, and procedural interventions. Pipeline includes 1 PHASE4, 1 PHASE3, 2 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT02393703](https://clinicaltrials.gov/study/NCT02393703) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:54 AM UTC
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer |
— |
Memorial Sloan Kettering Cancer Center |
RECRUITING |
[NCT06055010](https://clinicaltrials.gov/study/NCT06055010) | Improving Pancreatic Cancer Care by the Use of Computational Science and Technology | — | UMC Utrecht | RECRUITING |
[NCT06564571](https://clinicaltrials.gov/study/NCT06564571) | Artificial Intelligence in Endoscopic Ultrasound | — | Orlando Health, Inc. | RECRUITING |
[NCT06340620](https://clinicaltrials.gov/study/NCT06340620) | EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope | NA | Orlando Health, Inc. | RECRUITING |
[NCT04259580](https://clinicaltrials.gov/study/NCT04259580) | Calgary Registry for Advanced and Therapeutic Endoscopy | — | University of Calgary | RECRUITING |
155 publications have been identified in PubMed for pancreas disorder. Research spans Review / Meta-Analysis (34%), Basic Science / Preclinical (25%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 52 | 34% |
Laboratory research | 39 | 25% |
Disease patterns and progression | 24 | 15% |
Testing and diagnosis research | 12 | 8% |
New treatment approaches | 11 | 7% |
Patient case studies | 8 | 5% |
Clinical study results | 8 | 5% |
Other research | 1 | 1% |
Suphamungmee W (2026). [PMID: 42195206](https://pubmed.ncbi.nlm.nih.gov/42195206/). *Medicina (Kaunas)*. [Review / Meta-Analysis]
Wallace MB (2026). [PMID: 41498716](https://pubmed.ncbi.nlm.nih.gov/41498716/). *Gastroenterology*. [Review / Meta-Analysis]
Xu Y (2026). [PMID: 40938312](https://pubmed.ncbi.nlm.nih.gov/40938312/). *Int J Cancer*. [Diagnostic / Biomarker]
Zhang Q (2026). [PMID: 40990651](https://pubmed.ncbi.nlm.nih.gov/40990651/). *Int J Surg*. [Epidemiology / Natural History]
Wang C (2026). [PMID: 41818263](https://pubmed.ncbi.nlm.nih.gov/41818263/). *J Clin Invest*. [Basic Science / Preclinical]
Liu J (2026). [PMID: 41407209](https://pubmed.ncbi.nlm.nih.gov/41407209/). *Journal of controlled release : official journal of the Controlled Release Society*. [Gene Therapy / Novel Therapeutics]
Temprano AG (2026). [PMID: 40550113](https://pubmed.ncbi.nlm.nih.gov/40550113/). *Hepatology*. [Epidemiology / Natural History]
Wang Q (2026). [PMID: 41454639](https://pubmed.ncbi.nlm.nih.gov/41454639/). *Ann Med*. [Review / Meta-Analysis]
Downie JM (2026). [PMID: 41581946](https://pubmed.ncbi.nlm.nih.gov/41581946/). *Gastroenterology clinics of North America*. [Diagnostic / Biomarker]
Vujasinovic M (2026). [PMID: 41689768](https://pubmed.ncbi.nlm.nih.gov/41689768/). *United European Gastroenterol J*. [Review / Meta-Analysis]